SENSILICON
山海半导体
SENSILICON (山海半导体) is a Chinese precision signal-chain IC company that raised a 120 million RMB Series A round led by Cornerstone Capital with Hefei Industrial Investment following; existing shareholders BlueRun Ventures, Tongchuang Weiye, Shenzhen Capital Group, and Dalton Venture all re-upped . BlueRun Ventures led its angel round and has added to its position multiple times, including in the Series A . Dalton Venture, which frames SENSILICON as "a pioneer in China's precision signal-chain chip赛道," also holds a stake through both initial investment and follow-on . The company's financing is earmarked for accelerating its development, though the bundle does not detail specific product lines or founding date.
AI-generated — may contain errors, please verify.
Coverage
From Early Innovation to Industry Recognition: A Map of Dalton Venture's Specialized and Innovative Portfolio Companies
"Specialized, refined, distinctive, and innovative" enterprises are increasingly becoming a key benchmark for assessing the growth quality of China's technology and innovation companies. It represents not only a company's technical strength, innovation capability, and growth potential in niche sectors, but also serves as external validation from the industrial system of the value of outstanding SMEs. Recently, **Xuanyu Medical**, a **Dalton Venture family company**, was once again named to **Shanghai's second batch of 2026 specialized, refined, distinctive, and innovative SMEs. This marks Xuanyu Medical's continued recognition following its 2023 selection.
Facing the Challenges Head-On, Staying the Course | BlueRun Ventures Bi-Monthly Report
Believe in the Future
Spring in Full Bloom, Brilliance Across All Things | Dalton Venture's 2024 CEO Summit Successfully Held
The annual Two Sessions have always been a critical barometer for China's economic trajectory and policy direction. This March, when the government elevated "new quality productive forces" to the top of its work agenda, it sparked intense interest and vigorous debate across industries about this buzzword. As one of the most dynamic drivers of technological innovation and industrial transformation—and a strategic emerging industry that lies at the heart of future industrial planning—how should the medical sector translate new quality productive forces into practice? And where will it steer the development and transformation of the life sciences industry?
No Matter How Far, We Can Get There | August & September Bi-Monthly Report
Go Far Away
BlueRun Ventures Quarterly Investment Roundup | 2023 Q2
The sectors span AI, enterprise services, hard tech, and consumer technology.
Jui Chan, BlueRun Ventures: Riding the Waves — Don't Waste a Crisis | BlueRun Perspectives
Adaptability is the eternal question for investors.
You Can't Predict. You Can Prepare | April Report
Riding the Unpredictable Wave
Spring Tide Surges, A Thousand Sails Compete — Dalton Venture Annual CEO Summit | Tong Learning Society
Gather friends, gather energy, gather spirit
